A few weeks after Sarepta Therapeutics confirmed a patient died after receiving its drug Elevidys, research published April 3 ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Assertiveness—a communication style that involves frank self-expression while respecting others—is considered a teachable ...

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and ...

Cardinal Health’s Mike Brown, vice president of managed services, and Naveen Mansukhani, director of specialty and ambulatory ...

Specialty pharmacy has traditionally ... they stopped taking the drugs for provider-driven reasons, and 12.2% said they preferred other therapeutic options. The study notes that pharmacists ...

STUDY SAYS The DRUG Act's reforms serve to address this anti-competitiveness, which the bill's sponsors say will also help ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, ...

Pharmacy benefit managers ... PBM lobbyists are telling lawmakers to kill HB 740 and instead pass a bill to study the ...

New Delhi: Akums Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the ...

A new study shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.